Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2012 (2012), Article ID 423868, 10 pages
http://dx.doi.org/10.1155/2012/423868
Review Article

The Promise of Human Induced Pluripotent Stem Cells in Dental Research

1Research and Development Department, Hygieia Innovation Sdn. Bhd, Lot 1G-2G, Komplex Lanai, No.2, Persiaran Seri Perdana, Persint 10, Territory of Putrajaya, 62250 Federal, Malaysia
2Department of Conservative Dentistry, Faculty of Dentistry, University of Malaya, 50603 Kuala Lumpur, Malaysia
3Oral Cancer Research and Coordinating Centre (OCRCC), Faculty of Dentistry, University of Malaya, 50603 Kuala Lumpur, Malaysia
4Department of Oral Pathology, Oral Medicine and Periodontology, Faculty of Dentistry, University of Malaya, 50603 Kuala Lumpur, Malaysia
5Department of Children's Dentistry and Orthodontics, Faculty of Dentistry, University of Malaya, 50603 Kuala Lumpur, Malaysia

Received 21 November 2011; Revised 20 February 2012; Accepted 22 February 2012

Academic Editor: Rajarshi Pal

Copyright © 2012 Thekkeparambil Chandrabose Srijaya et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. X. Chen and F. Zeng, “Directed hepatic differentiation from embryonic stem cells,” Protein and Cell, vol. 2, no. 3, pp. 180–188, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. W. Deng, “Induced pluripotent stem cells: paths to new medicines,” EMBO Reports, vol. 11, no. 3, pp. 161–165, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Aasen, A. Raya, M. J. Barrero et al., “Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes,” Nature Biotechnology, vol. 26, no. 11, pp. 1276–1284, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. W. E. Lowry, L. Richter, R. Yachechko et al., “Generation of human induced pluripotent stem cells from dermal fibroblasts,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 8, pp. 2883–2888, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. H. Loh, S. Agarwal, I. H. Park et al., “Generation of induced pluripotent stem cells from human blood,” Blood, vol. 113, no. 22, pp. 5476–5479, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Haase, R. Olmer, K. Schwanke et al., “Generation of induced pluripotent stem cells from human cord blood,” Cell Stem Cell, vol. 5, no. 4, pp. 434–441, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. X. Yan, H. Qin, C. Qu, R. S. Tuan, S. Shi, and G. T. J. Huang, “iPs cells reprogrammed from human mesenchymal-like stem/progenitor cells of dental tissue origin,” Stem Cells and Development, vol. 19, no. 4, pp. 469–480, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Kunisato, M. Wakatsuki, H. Shinba, T. Ota, I. Ishida, and K. Nagao, “Direct generation of induced pluripotent stem cells from human nonmobilized blood,” Stem Cells and Development, vol. 20, no. 1, pp. 159–168, 2011. View at Publisher · View at Google Scholar
  9. N. Maherali, R. Sridharan, W. Xie et al., “Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution,” Cell Stem Cell, vol. 1, no. 1, pp. 55–70, 2007. View at Publisher · View at Google Scholar
  10. K. Okita, T. Ichisaka, and S. Yamanaka, “Generation of germline-competent induced pluripotent stem cells,” Nature, vol. 448, no. 7151, pp. 313–317, 2007. View at Publisher · View at Google Scholar
  11. I. H. Park, N. Arora, H. Huo et al., “Disease-specific induced pluripotent stem cells,” Cell, vol. 134, no. 5, pp. 877–886, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. S. M. Wu and K. Hochedlinger, “Harnessing the potential of induced pluripotent stem cells for regenerative medicine,” Nature Cell Biology, vol. 13, no. 5, pp. 497–505, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Takahashi, K. Tanabe, M. Ohnuki et al., “Induction of pluripotent stem cells from adult human fibroblasts by defined factors,” Cell, vol. 131, no. 5, pp. 861–872, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Amabile and A. Meissner, “Induced pluripotent stem cells: current progress and potential for regenerative medicine,” Trends in Molecular Medicine, vol. 15, no. 2, pp. 59–68, 2009. View at Publisher · View at Google Scholar
  15. K. Takahashi and S. Yamanaka, “Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors,” Cell, vol. 126, no. 4, pp. 663–676, 2006. View at Publisher · View at Google Scholar
  16. J. Yu, M. A. Vodyanik, K. S. Otto et al., “Induced pluripotent stem cell lines derived from human somatic cells,” Science, vol. 318, no. 5858, pp. 1917–1920, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. B. W. Carey, S. Markoulaki, J. Hanna et al., “Reprogramming of murine and human somatic cells using a single polycistronic vector,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 1, pp. 157–162, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Okita, M. Nakagawa, H. Hyenjong, T. Ichisaka, and S. Yamanaka, “Generation of mouse induced pluripotent stem cells without viral vectors,” Science, vol. 322, no. 5903, pp. 949–953, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Stadtfeld, M. Nagaya, J. Utikal, G. Weir, and K. Hochedlinger, “Induced pluripotent stem cells generated without viral integration,” Science, vol. 322, no. 5903, pp. 945–949, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Kaji, K. Norrby, A. Paca, M. Mileikovsky, P. Mohseni, and K. Woltjen, “Virus-free induction of pluripotency and subsequent excision of reprogramming factors,” Nature, vol. 458, no. 7239, pp. 771–775, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Woltjen, I. P. Michael, P. Mohseni et al., “PiggyBac transposition reprograms fibroblasts to induced pluripotent stem cells,” Nature, vol. 458, no. 7239, pp. 766–770, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. F. Soldner, D. Hockemeyer, C. Beard et al., “Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors,” Cell, vol. 136, no. 5, pp. 964–977, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Yu, K. Hu, K. S. Otto et al., “Human induced pluripotent stem cells free of vector and transgene sequences,” Science, vol. 324, no. 5928, pp. 797–801, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Kim, J. I. Moon, Y. G. Chung et al., “Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins,” Cell Stem Cell, vol. 4, no. 6, pp. 472–476, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Zhou, S. Wu, J. Y. Joo et al., “Generation of induced pluripotent stem cells using recombinant proteins,” Cell Stem Cell, vol. 4, no. 5, pp. 381–384, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. L. Warren, P. D. Manos, T. Ahfeldt et al., “Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA,” Cell Stem Cell, vol. 7, no. 5, pp. 618–630, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. S. Chun, P. Chaudhari, and Y. Y. Jang, “Applications of patient-specific induced pluripotent stem cells; focused on disease modeling, drug screening and therapeutic potentials for liver disease,” International Journal of Biological Sciences, vol. 6, no. 7, pp. 796–805, 2010. View at Google Scholar · View at Scopus
  28. N. Y. Kang, S. W. Yun, H. H. Ha, S. J. Park, and Y. T. Chang, “Embryonic and induced pluripotent stem cell staining and sorting with the live-cell fluorescence imaging probe CDy1,” Nature Protocols, vol. 6, no. 7, pp. 1044–1052, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Yu, K. F. Chau, M. A. Vodyanik, J. Jiang, and Y. Jiang, “Efficient feeder-free episomal reprogramming with small molecules,” Plos one, vol. 6, no. 3, Article ID e17557, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Ohnuki, K. Takahashi, and S. Yamanaka, “Generation and characterization of human induced pluripotent stem cells,” Current Protocols in Stem Cell Biology, vol. 4, pp. 4A.2.1–4A.2.25, 2009. View at Google Scholar · View at Scopus
  31. J. T. Dimos, K. T. Rodolfa, K. K. Niakan et al., “Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons,” Science, vol. 321, no. 5893, pp. 1218–1221, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. A. D. Ebert, J. Yu Jr., F. F. Rose et al., “Induced pluripotent stem cells from a spinal muscular atrophy patient,” Nature, vol. 457, no. 7227, pp. 277–280, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. O. Cooper, G. Hargus, M. Deleidi et al., “Differentiation of human ES and parkinson's disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acid,” Molecular and Cellular Neuroscience, vol. 45, no. 3, pp. 258–266, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Hargus, O. Cooper, M. Deleidi et al., “Differentiated parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in parkinsonian rats,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 36, pp. 15921–15926, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. N. Zhang, , M. C. An, D. Montoro, and L. M. Ellerby, “Characterization of human Huntington’s disease cell model from induced pluripotent stem cells,” PLoS Currents, vol. 2, Article ID RRN1193, 2010. View at Publisher · View at Google Scholar
  36. A. Hotta, A. Y. L. Cheung, N. Farra et al., “Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency,” Nature Methods, vol. 6, no. 5, pp. 370–376, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Lee, E. P. Papapetrou, H. Kim et al., “Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs,” Nature, vol. 461, no. 7262, pp. 402–406, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. S. J. Chamberlain, P. F. Chen, K. Y. Ng et al., “Induced pluripotent stem cell models of the genomic imprinting disorders angelman and prader-willi syndromes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 41, pp. 17668–17673, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Yang, J. Cai, Y. Zhang et al., “Induced pluripotent stem cells can be used to model the genomic imprinting disorder Prader-Willi syndrome,” The Journal of Biological Chemistry, vol. 285, no. 51, pp. 40303–40311, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Ku, E. Soragni, E. Campau et al., “Friedreich's ataxia induced pluripotent stem cells model intergenerational GAATTC triplet repeat instability,” Cell Stem Cell, vol. 7, no. 5, pp. 631–637, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. M. C. N. Marchetto, C. Carromeu, A. Acab et al., “A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells,” Cell, vol. 143, no. 4, pp. 527–539, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. K. J. Brennand, A. Simone, J. Jou et al., “Modelling schizophrenia using human induced pluripotent stem cells,” Nature, vol. 473, no. 7346, pp. 221–225, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Somers, J. C. Jean, C. A. Sommer et al., “Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette,” Stem Cells, vol. 28, no. 10, pp. 1728–1740, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. I. M. Pessach, J. Ordovas-Montanes, S. Y. Zhang et al., “Induced pluripotent stem cells: a novel frontier in the study of human primary immunodeficiencies,” Journal of Allergy and Clinical Immunology, vol. 127, no. 6, pp. 1400–1407, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. Y. Kazuki, M. Hiratsuka, M. Takiguchi et al., “Complete genetic correction of ips cells from duchenne muscular dystrophy,” Molecular Therapy, vol. 18, no. 2, pp. 386–393, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. Y. Wang, Y. Jiang, S. Liu, X. Sun, and S. Gao, “Generation of induced pluripotent stem cells from human β-thalassemia fibroblast cells,” Cell Research, vol. 19, no. 9, pp. 1120–1123, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. L. Ye, J. C. Chang, C. Lin, X. Sun, J. Yu, and Y. W. Kan, “Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 24, pp. 9826–9830, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. J. E. Carette, J. Pruszak, M. Varadarajan et al., “Generation of iPSCs from cultured human malignant cells,” Blood, vol. 115, no. 20, pp. 4039–4042, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Moretti, M. Bellin, A. Welling et al., “Patient-specific induced pluripotent stem-cell models for long-QT syndrome,” New England Journal of Medicine, vol. 363, no. 15, pp. 1397–1409, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. I. Itzhaki, L. Maizels, I. Huber et al., “Modelling the long QT syndrome with induced pluripotent stem cells,” Nature, vol. 471, no. 7337, pp. 225–239, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. R. Maehr, S. Chen, M. Snitow et al., “Generation of pluripotent stem cells from patients with type 1 diabetes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 37, pp. 15768–15773, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. X. Carvajal-Vergara, A. Sevilla, S. L. D'Souza et al., “Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome,” Nature, vol. 465, no. 7299, pp. 808–812, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. J. Tolar, I. H. Park, L. Xia et al., “Hematopoietic differentiation of induced pluripotent stem cells from patients with mucopolysaccharidosis type I (Hurler syndrome),” Blood, vol. 117, no. 3, pp. 839–847, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Raya, I. Rodriguez-Piz, G. Guenechea et al., “Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells,” Nature, vol. 460, no. 7251, pp. 53–59, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. S. T. Rashid, S. Corbineau, N. Hannan et al., “Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells,” Journal of Clinical Investigation, vol. 120, no. 9, pp. 3127–3136, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. A. Urbach, O. Bar-Nur, G. Q. Daley, and N. Benvenisty, “Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells,” Cell Stem Cell, vol. 6, no. 5, pp. 407–411, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. S. Agarwal, Y. H. Loh, E. M. McLoughlin et al., “Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients,” Nature, vol. 464, no. 7286, pp. 292–296, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. Z. B. Jin, S. Okamoto, F. Osakada et al., “Modeling retinal degeneration using patient-specific induced pluripotent stem cells,” PloS One, vol. 6, no. 2, Article ID e17084, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. J. S. Meyer, S. E. Howden, K. A. Wallace et al., “Optic vesicle-like structures derived from human pluripotent stem cells facilitate a customized approach to retinal disease treatment,” Stem Cells, vol. 29, no. 8, pp. 1206–1218, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. H. C. Slavkin, “The human genome, implications for oral health and diseases, and dental education,” Journal of Dental Education, vol. 65, no. 5, pp. 463–479, 2001. View at Google Scholar · View at Scopus
  61. H. O. Sedano, C. Freyre, M. L. Garza de la Garza et al., “Clinical orodental abnormalities in Mexican children,” Oral Surgery Oral Medicine and Oral Pathology, vol. 68, no. 3, pp. 300–311, 1989. View at Google Scholar · View at Scopus
  62. A. Mostowska, A. Kobielak, and W. H. Trzeciak, “Molecular basis of non-syndromic tooth agenesis: mutations of MSX1 and PAX9 reflect their role in patterning human dentition,” European Journal of Oral Sciences, vol. 111, no. 5, pp. 365–370, 2003. View at Publisher · View at Google Scholar · View at Scopus
  63. B. L. Pihlstrom, B. S. Michalowicz, and N. W. Johnson, “Periodontal diseases,” The Lancet, vol. 366, no. 9499, pp. 1809–1820, 2005. View at Publisher · View at Google Scholar · View at Scopus
  64. P. E. Petersen, D. Bourgeois, H. Ogawa, S. Estupinan-Day, and C. Ndiaye, “The global burden of oral diseases and risks to oral health,” Bulletin of the World Health Organization, vol. 83, no. 9, pp. 661–669, 2005. View at Google Scholar · View at Scopus
  65. P. J. M. Crawford, M. J. Aldred, and A. Clarke, “Clinical and radiographic dental findings in X linked hypohidrotic ectodermal dysplasia,” Journal of Medical Genetics, vol. 28, no. 3, pp. 181–185, 1991. View at Google Scholar · View at Scopus
  66. B. S. Gonzalez Lepez, C. Ortiz Solalinde, T. I. Kubodera, E. Lara Carrillo, and E. Ortiz Solalinde, “Cleido cranial dysplasia: report of a family,” Journal of Oral Science, vol. 46, no. 4, pp. 259–266, 2004. View at Google Scholar · View at Scopus
  67. M. M. Cohen Jr. and S. Kreiborg, “Perspectives on craniofacial syndromes,” Acta Odontologica Scandinavica, vol. 56, no. 6, pp. 315–320, 1998. View at Publisher · View at Google Scholar · View at Scopus
  68. H. V. Toriello, “Oral-facial-digital syndromes,” Clinical Dysmorphology, vol. 2, no. 2, pp. 95–105, 1992. View at Google Scholar · View at Scopus
  69. S. A. Feather, A. S. Woolf, D. Donnai, S. Malcolm, and R. M. Winter, “The oral-facial-digital syndrome type 1 (OFD1), a cause of polycystic kidney disease and associated malformations, maps to Xp22.2-Xp22.3,” Human Molecular Genetics, vol. 6, no. 7, pp. 1163–1167, 1997. View at Publisher · View at Google Scholar · View at Scopus
  70. M. I. Ferrante, G. Giorgio, S. A. Feather et al., “Identification of the gene for oral-facial-digital type 1 syndrome,” American Journal of Human Genetics, vol. 68, no. 3, pp. 569–576, 2001. View at Publisher · View at Google Scholar · View at Scopus
  71. P. Hedera and J. L. Gorski, “Oculo-facio-cardio-dental syndrome: skewed X chromosome inactivation in mother and daughter suggest X-linked dominant inheritance,” American Journal of Medical Genetics, vol. 123, no. 3, pp. 261–266, 2003. View at Google Scholar · View at Scopus
  72. E. McGovern, M. AL-Mudaffer, C. McMahon, D. Brosnahan, P. Fleming, and W. Reardon, “Oculo-facio-cardio-dental syndrome in a mother and daughter,” International Journal of Oral and Maxillofacial Surgery, vol. 35, no. 11, pp. 1060–1062, 2006. View at Publisher · View at Google Scholar · View at Scopus
  73. J. T. Wright, M. J. Aldred, K. Seow et al., “Relationship of phenotype and genotype in X-linked amelogenesis imperfecta,” Connective Tissue Research, vol. 44, no. 1, pp. 72–78, 2003. View at Google Scholar · View at Scopus
  74. J. Mangion, N. Rahman, S. Edkins et al., “The gene for cherubism maps to chromosome 4p16.3,” American Journal of Human Genetics, vol. 65, no. 1, pp. 151–157, 1999. View at Publisher · View at Google Scholar · View at Scopus
  75. M. L. Beattie, J. W. Kim, S. G. Gong, C. A. Murdoch-Kinch, J. P. Simmer, and J. C. C. Hu, “Phenotypic variation in dentinogenesis imperfecta/dentin dysplasia linked to 4q21,” Journal of Dental Research, vol. 85, no. 4, pp. 329–333, 2006. View at Publisher · View at Google Scholar · View at Scopus
  76. K. S. Kornman, A. Crane, H. Y. Wang et al., “The interleukin-1 genotype as a severity factor in adult periodontal disease,” Journal of Clinical Periodontology, vol. 24, no. 1, pp. 72–77, 1997. View at Google Scholar · View at Scopus
  77. C. C. Pontes, J. R. Gonzales, A. B. Novaes et al., “Interleukin-4 gene polymorphism and its relation to periodontal disease in a Brazilian population of African heritage,” Journal of Dentistry, vol. 32, no. 3, pp. 241–246, 2004. View at Publisher · View at Google Scholar · View at Scopus
  78. P. Das, D. W. Stockton, C. Bauer et al., “Haploinsufficiency of PAX9 is associated with autosomal dominant hypodontia,” Human Genetics, vol. 110, no. 4, pp. 371–376, 2002. View at Publisher · View at Google Scholar · View at Scopus
  79. L. Lammi, K. Halonen, S. Pirinen, I. Thesleff, S. Arte, and P. Nieminen, “A missense mutation in PAX9 in a family with distinct phenotype of oligodontia,” European Journal of Human Genetics, vol. 11, no. 11, pp. 866–871, 2003. View at Publisher · View at Google Scholar · View at Scopus
  80. T. Yoshida, H. Kanegane, M. Osato et al., “Functional analysis of RUNX2 mutations in Japanese patients with cleidocranial dysplasia demonstrates novel genotype-phenotype correlations,” American Journal of Human Genetics, vol. 71, no. 4, pp. 724–738, 2002. View at Google Scholar · View at Scopus
  81. R. Mendoza-Londono and R. Lee, “Cleidocranial dysplasia,” Gene Reviews, Bookshelf ID: NBK1513, 2009, http://www.genetests.org.
  82. J. K. Northup, R. Matalon, L. H. Lockhart, J. C. Hawkins, and G. V. N. Velagaleti, “A complex chromosome rearrangement, der(6)ins(6)(p21.1q25.3q27)inv(6)(p25.3q27), in a child with cleidocranial dysplasia,” European Journal of Medical Genetics, vol. 54, no. 4, pp. e394–e398, 2011. View at Publisher · View at Google Scholar · View at Scopus
  83. C. Ged, H. Megarbane, E. Chouery, M. Lalanne, A. Megarbane, and H. de Verneuil, “Congenital erythropoietic porphyria: report of a novel mutation with absence of clinical manifestations in a homozygous mutant sibling,” Journal of Investigative Dermatology, vol. 123, no. 3, pp. 589–591, 2004. View at Publisher · View at Google Scholar · View at Scopus
  84. J. Kere, A. K. Srivastava, O. Montonen et al., “X-linked anhidrotic (hypohidrotic) ectodermal dysplasia is caused by mutation in a novel transmembrane protein,” Nature Genetics, vol. 13, no. 4, pp. 409–416, 1996. View at Publisher · View at Google Scholar · View at Scopus
  85. J. Amiel, G. Bougeard, C. Francannet et al., “TP63 gene mutation in ADULT syndrome,” European Journal of Human Genetics, vol. 9, no. 8, pp. 642–645, 2001. View at Publisher · View at Google Scholar · View at Scopus
  86. J. D. Fine, R. A. J. Eady, E. A. Bauer et al., “Revised classification system for inherited epidermolysis bullosa: report of the Second International Consensus Meeting on diagnosis and classification of epidermolysis bullosa,” Journal of the American Academy of Dermatology, vol. 42, no. 6, pp. 1051–1066, 2000. View at Publisher · View at Google Scholar · View at Scopus
  87. R. E. Cummins, S. Klingberg, J. Wesley, M. Rogers, Y. Zhao, and D. F. Murrell, “Keratin 14 point mutations at codon 119 of helix 1a resulting in different epidermolysis bullosa simplex phenotypes,” Journal of Investigative Dermatology, vol. 117, no. 5, pp. 1103–1107, 2001. View at Publisher · View at Google Scholar · View at Scopus
  88. T. Kobayashi, K. Narahara, Y. Yokoyama et al., “Gardner syndrome in a boy with interstitial deletion of the long arm of chromosome 5,” American Journal of Medical Genetics, vol. 41, no. 4, pp. 460–463, 1991. View at Google Scholar · View at Scopus
  89. M. Ehrenreich, M. M. Tarlow, E. Godlewska-Janusz, and R. A. Schwartz, “Incontinentia pigmenti (Bloch-Sulzberger syndrome): a systemic disorder,” Cutis, vol. 79, no. 5, pp. 355–362, 2007. View at Google Scholar · View at Scopus
  90. N. V. Whittock, C. M. Coleman, W. H. I. Mclean et al., “The gene for Naegeli-Franceschetti-Jadassohn syndrome maps to 17q21,” Journal of Investigative Dermatology, vol. 115, no. 4, pp. 694–698, 2000. View at Publisher · View at Google Scholar · View at Scopus
  91. T. C. Hart, P. S. Hart, D. W. Bowden et al., “Mutations of the cathepsin C gene are responsible for Papillon-Lefévre syndrome,” Journal of Medical Genetics, vol. 36, no. 12, pp. 881–887, 1999. View at Google Scholar · View at Scopus
  92. M. Pigg, S. Jagell, A. Sillén, J. Weissenbach, K. H. Gustavson, and C. Wadelius, “The Sjögren-Larsson syndrome gene is close to D17S805 as determined by linkage analysis and allelic association,” Nature Genetics, vol. 8, no. 4, pp. 361–364, 1994. View at Publisher · View at Google Scholar · View at Scopus
  93. V. de Laurenzi, G. R. Rogers, D. J. Hamrock et al., “Sjögren-Larsson syndrome is caused by mutations in the fatty aldehyde dehydrogenase gene,” Nature Genetics, vol. 12, no. 1, pp. 52–57, 1996. View at Google Scholar · View at Scopus
  94. C. Estrela, A. H. G. de Alencar, G. T. Kitten, E. F. Vencio, and E. Gava, “Mesenchymal stem cells in the dental tissues: perspectives for tissue regeneration,” Brazilian Dental Journal, vol. 22, no. 2, pp. 91–98, 2011. View at Google Scholar · View at Scopus
  95. P. C. B. Beltrão-Braga, G. C. Pignatari, P. C. Maiorka et al., “Feeder-free derivation of induced pluripotent stem cells from human immature dental pulp stem cells,” Cell Transplantation, vol. 20, no. 11-12, pp. 1707–1719, 2011. View at Publisher · View at Google Scholar
  96. J. Hanna, M. Wernig, S. L. Markoulaki et al., “Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin,” Science, vol. 318, no. 5858, pp. 1920–1923, 2007. View at Publisher · View at Google Scholar · View at Scopus
  97. R. R. Nadig, “Stem cell therapy—hype or hope? A review,” Journal of Conservative Dentistry, vol. 12, no. 4, pp. 131–138, 2009. View at Publisher · View at Google Scholar
  98. T. Yoshida, K. Washio, T. Iwata, T. Okano, and I. Ishikawa, “Current status and future development of cell transplantation therapy for periodontal tissue regeneration,” International Journal of Dentistry, vol. 2012, Article ID 307024, 8 pages, 2012. View at Publisher · View at Google Scholar
  99. S. Sood, S. Gupta, and A. Mahendra, “Gene therapy with growth factors for periodontal tissue engineering—a review,” Medicina Oral, Patología Oral y Cirugía Bucal, vol. 12, no. 2, pp. e301–e310, 2012. View at Google Scholar
  100. J. E. Nör, “Tooth regeneration in operative dentistry,” Operative Dentistry, vol. 31, no. 6, pp. 633–642, 2006. View at Publisher · View at Google Scholar · View at Scopus
  101. F. F. Demarco, M. C. M. Conde, B. N. Cavalcanti, L. Casagrande, V. T. Sakai, and J. E. Nör, “Dental pulp tissue engineering,” Brazilian Dental Journal, vol. 22, no. 1, pp. 3–14, 2011. View at Google Scholar · View at Scopus